Objective. Our aim was to assess the outcome of pregnancy in a cohort of patients with SLE
and to evaluate clinical and laboratory markers for fetal outcome and maternal flares …

Background: The potential role of new oral anticoagulants in antiphospholipid antibody
syndrome (APS) remains uncertain. Objective: To determine whether rivaroxaban is …

MicroRNAs (miRNAs) are endogenous small non-coding RNA molecules that regulate the
gene expression at a post-transcriptional level and participate in maintaining the correct cell …

Background Despite overall improvement in prognosis, 10–30% of patients with lupus
nephritis (LN) will develop end-stage renal disease. To date, renal biopsy is still the 'gold …

For lupus nephritis (LN) management, it is very important to detect fibrosis at an early stage.
Urinary exosomal miRNAs profiling can be used as a potential multi-marker phenotyping …

Background Although thalidomide has been shown to be effective in patients with refractory
cutaneous lupus erythematosus (CLE), its use is still hampered by its potential severe side …

PURPOSE: We sought to assess the nephritogenic antibody profile of patients with systemic
lupus erythematosus (SLE), and to determine which antibodies were most useful in …

Introduction One of the most important aims in the management of systemic lupus
erythematosus (SLE) is to avoid or delay the accumulation of organ damage. The first five …

Data on exosomal-derived urinary miRNAs have identified several miRNAs associated with
disease activity and fibrosis formation, but studies on prognosis are lacking. We conducted a …

Objective To compare the efficacy and safety of enteric-coated mycophenolate sodium (EC-
MPS) versus azathioprine (AZA) in patients with active systemic lupus erythematosus (SLE) …